Successful use of secukinumab in a 4-year-old patient with deficiency of interleukin-36 antagonist

Rheumatology (Oxford). 2018 May 1;57(5):936-938. doi: 10.1093/rheumatology/kex510.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Psoriatic / diagnosis
  • Arthritis, Psoriatic / drug therapy*
  • Biomarkers / metabolism
  • Child
  • Female
  • Follow-Up Studies
  • Humans
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-1 / deficiency*
  • Interleukin-17 / antagonists & inhibitors
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Biomarkers
  • Interleukin-1
  • Interleukin-17
  • interleukin 36, human
  • secukinumab